Consensus Alkem Laboratories Limited Bombay S.E.

Stocks

ALKEM

INE540L01014

Pharmaceuticals

Market Closed - Bombay S.E. 06:02:30 2026-09-01 am EDT			5-day change	1st Jan Change
5,300.00 ^INR	-1.00%		-0.99%	-3.73%

Aug. 14	Alkem Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026
Aug. 14	Alkem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Evolution of the Average Target: Alkem Laboratories Limited

Evolution of the Target Price: Alkem Laboratories Limited

Changes in Analyst Recommendations: Alkem Laboratories Limited

8b44cc6abb40889ef47b33c2863.2hiHUia8PzGbaJZg-mKRFhNBllzmhyKuL9PcLcVAdU8.62izJFXqVXX8XNwWjhfwbEcr_j3fsVTXToCFdfwtQTieb7YTF84ORKsv9Q~342024d8c16a1c7c0c128b4878610e15

Analysts' recommendations: Alkem Laboratories Limited

May. 29	Bob Capital Markets Downgrades Alkem Laboratories to Sell From Hold; Price Target is INR4,638	MT
May. 29	Jefferies Adjusts Alkem Laboratories' Price Target to INR6,500 From INR6,550, Keeps at Buy	MT
Feb. 16	Nomura Adjusts Alkem Laboratories' Price Target to INR6,890 From INR 6,860, Keeps at Buy	MT
Feb. 16	IIFL Upgrades Alkem Laboratories to Buy from Add, Price Target is INR6,300	MT
Nov. 17	Nomura Adjusts Alkem Laboratories' Price Target to INR6,860 From INR6,300, Keeps at Buy	MT
25-08-22	Nomura Adjusts Alkem Laboratories' Price Target to INR6,300 From INR5,430, Keeps at Buy	MT
25-08-13	Jefferies Upgrades Alkem Laboratories to Buy From Underperform, Adjusts Price Target to INR6,000 From INR4,460	MT
25-05-30	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,460 From INR4,580, Keeps at Underperform	MT
25-02-27	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR5,430 From INR5,670	MT
25-02-10	Nomura Adjusts Alkem Laboratories' Price Target to INR5,670 From INR6,097, Keeps at Neutral	MT
25-02-10	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,580 From INR5,080, Keeps at Underperform	MT
24-11-15	Nomura Adjusts Alkem Laboratories' Price Target to INR6,097 From INR6,061, Keeps at Neutral	MT
24-11-14	Jefferies Adjusts Alkem Laboratories' Price Target to INR4,950 From INR5,080, Keeps at Underperform	MT
24-08-14	Nomura Adjusts Alkem Laboratories' Price Target to INR6,061 From INR5,605, Keeps at Neutral	MT
24-08-12	Jefferies Adjusts Alkem Laboratories' Price Target to INR5,080 From INR4,200, Keeps at Underperform	MT
24-05-30	Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,200 From INR4,470, Keeps at Underperform	MT
24-02-12	Jefferies Adjusts Alkem Laboratories’ Price Target to INR4,470 From INR3,960, Keeps at Underperform	MT
23-11-09	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR4,963 From INR3,632	MT
23-11-08	Jefferies Adjusts Alkem Laboratories’ Price Target to INR3,600 From INR3,550, Keeps at Underperform	MT
23-08-11	Jefferies Adjusts Alkem Laboratories' Price Target to INR3,550 From INR2,800, Keeps at Underperform	MT
23-05-23	Nomura Downgrades Alkem Laboratories to Neutral From Buy, Adjusts Price Target to INR3,632 From INR3,772	MT
23-02-14	Nomura Adjusts Alkem Laboratories' Price Target to INR3,772 From INR3,602, Keeps at Buy	MT
23-02-13	Jefferies Adjusts Alkem Laboratories' Price Target to INR2,800 From INR2,600, Keeps at Underperform	MT
23-01-10	Nomura Upgrades Alkem Laboratories to Buy From Neutral, Adjusts Price Target to INR3,602 From INR3,487	MT

More recommendations

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ELI LILLY AND COMPANY					+13.69%
	JOHNSON & JOHNSON					+2.5%
	ABBVIE INC.					+7.86%
	ROCHE HOLDING AG					+4.96%
	NOVARTIS AG					+1.22%
	ASTRAZENECA PLC					+31.03%
	AMGEN INC.					-9.63%
	NOVO NORDISK A/S					+5.93%
	GILEAD SCIENCES, INC.					+7.56%
	Average					+7.24%
	Weighted average by Cap.					+8.13%